So looks like Mylan bought their way out of the contract imo, so what use is a contract with a big pharma if it can't be honoured by the courts.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025